CRP and ischemic stroke: A considerable proportion (66%) of the included patients had hs-CRP ≥2 mg/L in association with an increased risk of major adverse cardiovascular events (a composite endpoint of nonfatal MI, nonfatal ischemic stroke or cardiovascular death).